Figure 2.

Predicted mean hemoglobin response during the first year on zidovudine and non-zidovudine-based cART regimens stratified by baseline hemoglobin

Lines are drawn for zidovudine (solid) and non-zidovudine-based (dashed) regimens, and stratified by the 10^th (7.7 g/dL, green), 25^th (9.2 g/dL, blue), 75^th (11.8 g/dL, yellow), and 90^th (13.0 g/dL, red) percentiles of baseline hemoglobin. Adjusted to female sex and cotrimoxazole use.